ADIPOQ and diabetes mellitus: Adipokines may also be contributing factors as our earlier work demonstrated significantly lower circulating adiponectin levels in stroke survivors with diabetes, than those with impaired glucose tolerance and highest levels observed in stroke patients with normal glucose tolerance [28].